← Back to headlines
Insulet Downgraded by Oppenheimer Due to Growing Risks
Medical device company Insulet received a downgrade from Oppenheimer, citing increasing risks associated with the company's outlook.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
SpaceX Stock Plummets After Financial Results and AI Spending Concerns
9m ago
Wall Street Continues Upward Trend, Dow Jones Reaches New High
12m ago
Four Corners Property Trust Acquires Five Novant Health Urgent Care Properties for $11.7M
13m ago
Skyward Outlines $100M Buyback Authorization as Operating EPS Rises to $1.30
13m ago